Immunotherapy is a major emerging treatment for breast cancer (BC). However, not all
breast cancer patients derive benefit from immunotherapy. Predictive biomarkers of …

Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …

Introduction Breast carcinoma (BC) is one of the most frequent causes of cancer-related
death among women, which is due to the poor response to conventional therapy. There are …

Next‐generation cancer treatments are expected not only to target cancer cells but also to
simultaneously train immune cells to combat cancer while modulating the immune …

Breast cancer continues to be the most frequently diagnosed malignancy among women,
putting their life in jeopardy. Cancer immunotherapy is a novel approach with the ability to …

Cancer is a heterogeneous disease, occurs due to transcriptional changes in genetic and
epigenetic including numerous genes and proteins. Worldwide, breast cancer (BC) is the life …

Breast cancer (BC), one of the most widespread and devastating diseases affecting women
worldwide, presents a significant public health challenge. This review explores the emerging …

Triple-negative breast cancer (TNBC) exhibits high recurrence and mortality rates because
of the lack of effective treatment targets. Surgery and traditional chemotherapy are the …

Breast cancer remains a significant clinical concern affecting millions of women worldwide.
Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but …

Breast cancer (BC) is known to be a highly heterogeneous disease that is clinically
subdivided into four primary molecular subtypes, each having distinct morphology and …